The forward P/E discount of roughly 23% versus the historical average is the most compelling valuation signal, as it provides a margin of safety while still reflecting confidence in earnings acceleration; this gap could translate into upside if NPKI delivers its projected growth.
The forward P/E still exceeds the sector median of roughly 20x, meaning any shortfall in earnings growth would compress valuation sharply; a 5% miss on projected EPS could push the forward P/E above 25x, eroding the current discount to historical averages and pressuring the stock price.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 2.0% (normalized) (10Y CAGR) | Analyst Rev × 21.8% margin |
| PV of FCF | $203.2M | $71.1M |
| Terminal Value (PV) | $576.8M | $1.14B |
| Enterprise Value | $780.0M | $1.21B |
| Equity Value | $748.6M | $1.18B |
| Implied Stock Price | $10.21 | $16.13 |
| Upside/Downside | -30.1% | +10.3% |
| WACC \ Growth | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | $13 | $14 | $15 | $17 | $19 |
| 7.3% | $11 | $11 | $12 | $13 | $15 |
| 8.3% | $9 | $10 | $10 | $11 | $12 |
| 9.3% | $8 | $8 | $9 | $9 | $10 |
| 10.3% | $7 | $7 | $8 | $8 | $9 |
| WACC \ Growth | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | $19 | $21 | $24 | $27 | $31 |
| 7.3% | $16 | $18 | $19 | $21 | $24 |
| 8.3% | $14 | $15 | $16 | $18 | $19 |
| 9.3% | $12 | $13 | $14 | $15 | $16 |
| 10.3% | $11 | $12 | $12 | $13 | $14 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $23.23 | +58.9% | Peer median P/E (37.3x) × Forward EPS ($0.62) |
| P/B (Peer) | $8.58 | -41.3% | Peer median P/B (1.69x) × Book Value per Share |
| EV/EBITDA (Peer) | $8.03 | -45.1% | Peer median EV/EBITDA (9.9x) × EBITDA - Net Debt |
| P/S (Peer) | $5.16 | -64.7% | Peer median P/S (1.29x) × Revenue per Share |
| DCF | $10.21 | -30.1% | Revenue × FCF Margin projection (normalized FCF) |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net